Want to see ELDN full AI Analyst Report?
Eledon Pharmaceuticals (ELDN) Q2 2026 Earnings Report
ELDN Q2 2026 EPS Results
- Actual EPS
- -$0.27
- Consensus EPS
- -$0.16
- Beat/Miss
- Missed by -$0.11
- One Year Ago EPS
- -$0.13
ELDN Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- After Close
- Conference Call
- Thursday, August 13, 2026
ELDN Upcoming Earnings
Eledon Pharmaceuticals's next earnings date is estimated for November 18, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
ELDN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 18, 2026 | 2026 (Q3) | -0.19- | -0.21 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | -0.16-0.27 | -0.13 | -107.69% (-0.14) | |
| May 13, 2026 | 2026 (Q1) | -0.18-0.33 | -0.08 | -312.50% (-0.25) | |
| Mar 19, 2026 | 2025 (Q4) | -0.20-0.11 | -0.64 | 82.81% (+0.53) | |
| Nov 14, 2025 | 2025 (Q3) | -0.25-0.21 | -0.32 | 34.38% (+0.11) | |
| Aug 14, 2025 | 2025 (Q2) | -0.23-0.13 | -1.06 | 87.74% (+0.93) | |
| May 14, 2025 | 2025 (Q1) | -0.26-0.08 | -0.34 | 76.47% (+0.26) | |
| Mar 20, 2025 | 2024 (Q4) | -0.31-0.64 | -0.32 | -100.00% (-0.32) | |
| Nov 12, 2024 | 2024 (Q3) | -0.32-0.32 | -0.35 | 8.57% (+0.03) | |
| Aug 08, 2024 | 2024 (Q2) | -0.30-0.36 | -0.4 | 10.00% (+0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
